All stock lists
Twist Bioscience Corp (NASDAQ:TWST)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
145.25+5.33 (+3.81%)
Market cap
$9.56B
Health Score
Analyst consensus
Listed since
Oct 31, 2018
Website
Insider Score
––Not scored
TWST Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
TWST analyst forecast
TWST analyst consensus
Moderate Buy8 ratings
Buy 7 Hold 0 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TWST 12-month price target
$170.00+17.0% upsideaverage of 2 firms
$190.00High
$150.00Low
Best analysts covering TWST
- Guggenheim100%success rate · 1 call
- Evercore ISI Group50%success rate · 4 calls
- Barclays44%success rate · 18 calls
- Baird38%success rate · 8 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TWST analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-13 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-10-12 |
| Jefferies | — | $150.00 | -3.6% | — | 2026-10-08 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-07 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-10-01 |
| Leerink Partners | Outperform | $190.00 | +4.3% | Reiterated | 2026-09-29 | |
| — | BWS Financial | Sell | — | — | Reiterated | 2026-09-18 |
| Leerink Partners | Outperform | $160.00 | +11.8% | Reiterated | 2026-09-17 | |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-08-05 |
| — | Baird | Outperform | — | — | Reiterated | 2026-08-04 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-07-14 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2026-07-06 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-06-29 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-24 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-06-15 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-06-11 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-05-05 |
| — | Leerink Partners | Outperform | — | — | Upgraded | 2026-05-05 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-05-05 |
| — | Baird | Outperform | — | — | Reiterated | 2026-05-05 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-04-14 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-04-06 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-03-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-03 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-02-03 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-01-26 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-01-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-12-15 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-11-17 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2025-10-07 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-02 |
| — | Baird | Outperform | — | — | Reiterated | 2025-05-06 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-05-06 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-05-06 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-05-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-04-10 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2025-02-04 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2025-02-04 |
| — | Baird | Outperform | — | — | Reiterated | 2025-02-04 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-11-26 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-11-19 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-19 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-11-19 |
| — | Leerink Partners | Market Perform | — | — | Reiterated | 2024-10-17 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-10-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-08-05 |
| — | JP Morgan | Underweight | — | — | Reiterated | 2024-08-05 |
| — | Baird | Outperform | — | — | Reiterated | 2024-08-05 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-07-09 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-06-28 |
| — | TD Cowen | Buy | — | — | Reiterated | 2024-06-13 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-05-06 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2024-05-03 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-05-03 |
| — | Baird | Outperform | — | — | Reiterated | 2024-05-03 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-04-10 |
| — | Scotiabank | Sector Outperform | — | — | Reiterated | 2024-02-05 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-01-25 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2024-01-18 |
| — | Goldman Sachs | Buy | — | — | Upgraded | 2024-01-17 |
TWST earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-02 | -0.48 | -0.50 | $101.9M | $103.7M |
| 2026-05-04 | -0.49 | -0.71 | $107.6M | $110.7M |
| 2026-08-03 | -0.51 | -0.56 | $114.5M | $118.4M |
| 2026-11-13 | -0.38 | 0.00 | $123.6M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.